NCT01892085

Brief Summary

Compelling evidence exists that breast milk helps protect very premature infants from prematurity-specific morbidities. Unfortunately, mothers of premature infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and decreased breast milk production. Several studies have linked earlier initiation of breast milk expression following delivery with a greater milk production. However, none conclusively determined the optimal timing of breast milk expression. As a result these mothers continue to struggle with inadequate breast milk production. This study will follow 180 mothers of premature infants for 6 weeks following delivery to test Earlier initiation of breast milk expression following delivery is associated with (1) an earlier lactogenesis stage II, (2) greater volume of breast milk production during the first 6 weeks, (3) improved short-term infant health outcomes and (4) women who deliver at an earlier gestation will have decreased milk production and a later lactogenesis stage II. Following stratification according to the gestational age of the infant (23-27 weeks vs. 28-32 weeks), eligible women will be randomly assigned to one of three groups and instructed to start mechanically expressing their r breasts, either in the first hour, 1-3 hours or 3-6 hours following delivery. The timing of lactogenesis stage II will be documented, and the volume of breast milk produced will continue to be measured for the first 6 weeks following delivery and at discharge. Infant nutritional outcomes will be measured throughout the 6-week study. The impact of the differences in timing of initiation of milk expression following delivery on timing of lactogenesis stage II, milk volume, short term nutritional outcomes, amount of breast milk feedings at discharge, and impact of gestational age on milk volume and lactogenesis stage II will be determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 3, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
6.1 years until next milestone

Results Posted

Study results publicly available

August 24, 2023

Completed
Last Updated

August 24, 2023

Status Verified

July 1, 2023

Enrollment Period

3.8 years

First QC Date

June 28, 2013

Results QC Date

April 11, 2023

Last Update Submit

July 31, 2023

Conditions

Keywords

Breast milklactogenesis stage twopremature infantinsufficient milk supplybreast milk expression

Outcome Measures

Primary Outcomes (12)

  • Pumped Milk Volume Day 1

    Volume of pumped milk on day 1 postpartum

    Day 1 postpartum

  • Pumped Milk Volume on Day 2

    Volume of breast milk pumped on day 2 postpartum

    Day 2 postpartum

  • Pumped Milk Volume Day 3

    Volume of milk pumped on day 3 postpartum

    Day 3 postpartum

  • Pumped Milk Volume Day 4

    Volume of pumped milk on Day 4 postpartum

    Day 4 postpartum

  • Pumped Milk Volume on Day 5

    Volume of pumped milk on Day 5 postpartum

    Day 5 postpartum

  • Pumped Milk Volume Day 6

    Volume of pumped milk on Day 6 postpartum

    Day 6 postpartum

  • Pumped Milk Volume on Day 7

    Volume of milk pumped on day 7 postpartum

    Day 7 postpartum

  • Pumped Milk Volume at Day 14

    Volume of pumped milk on day 14 postpartum

    Day 14 postpartum

  • Pumped Milk Volume Day 21

    Volume of milk pumped on day 21 postpartum

    Day 21 postpartum

  • Pumped Milk Volume Day 28

    Volume of milk pumped on day 28 postpartum

    Day 28 postpartum

  • Pumped Milk Volume on Day 35

    Volume of milk pumped on day 35 postpartum

    Day 35 postpartum

  • Pumped Milk Volume on Day 42

    Volume of milk pumped on day 42 postpartum

    Day 42 postpartum

Secondary Outcomes (9)

  • Hours From Birth to Onset of Lactogenesis Stage 2

    Hours from birth to onset of lactogenesis stage 2

  • Days Lactated

    birth to approximately 3 months

  • Percentage of Feeds Consisting of Mother's Own Milk Week 1

    Day 1 to 7

  • Percentage of Feeds Consisting of Mother's Own Milk Week 2 Consumed by Infants

    Day 7-14

  • Percentage of Feeds Consisting of Mother's Own Milk Week 3

    Day 14-21

  • +4 more secondary outcomes

Study Arms (3)

Early initiation

EXPERIMENTAL

Initiation of breast milk expression \<1 hour following delivery.

Behavioral: Early initiation

Intermediate expression

EXPERIMENTAL

Initiation of milk expression 1-\<3 hours following delivery.

Behavioral: Intermediate expression

Late initiation

OTHER

Initiation of milk expression \>3-6 hours following delivery.

Behavioral: Late initiation

Interventions

Initiation of breast milk expression \<1 hour following delivery.

Also known as: Early initiation of breast milk expressed
Early initiation

Initiation of milk expression 1-\<3 hours following delivery.

Also known as: Intermediate timing of breast milk expression
Intermediate expression
Late initiationBEHAVIORAL

Initiation of milk expression \>3-6 hours following delivery.

Also known as: Late initiation of breast milk expression.
Late initiation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) at least 18 years of age,
  • \) English or Spanish-speaking,
  • \) stated intent to breastfeed,
  • \) anticipating the birth of a very low birth weight infant (≤1500 grams) between 23-32 weeks gestation.

You may not qualify if:

  • \) known illicit maternal drug use,
  • \) history of breast reduction or augmentation,
  • \) positive HIV status,
  • \) mother not transported to recovery by 45 minutes following delivery or
  • \) infant not expected to live over 2 weeks following delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida Shands

Gainesville, Florida, 32605, United States

Location

Related Publications (1)

  • Parker LA, Sullivan S, Cacho N, Krueger C, Mueller M. Effect of Postpartum Depo Medroxyprogesterone Acetate on Lactation in Mothers of Very Low-Birth-Weight Infants. Breastfeed Med. 2021 Oct;16(10):835-842. doi: 10.1089/bfm.2020.0336. Epub 2021 Apr 28.

MeSH Terms

Conditions

Breast Milk ExpressionPremature Birth

Condition Hierarchy (Ancestors)

Breast FeedingFeeding BehaviorBehaviorObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Results Point of Contact

Title
Leslie Parker
Organization
University of Florida

Study Officials

  • Leslie A Parker, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2013

First Posted

July 3, 2013

Study Start

November 1, 2013

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

August 24, 2023

Results First Posted

August 24, 2023

Record last verified: 2023-07

Locations